M1 Schizophrenia PET Study

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 20, 2021

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2023

Conditions
SchizophreniaSchizoaffective DisorderHealthy
Interventions
DRUG

11C-EMO - A Novel PET Radiotracer for Muscarinic M1 Receptor

The radiotracer, \[11C\]EMO, will be administered at the beginning of each PET scan.

DEVICE

PET Scan

PET scanner with high sensitivity and resolution available for human brain imaging

Trial Locations (1)

06519

Connecticut Mental Health Center, New Haven

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Yale University

OTHER